A5089030990- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Health, psychology, and well-being
- Emergency and Acute Care Studies
- Streptococcal Infections and Treatments
- Climate Change and Health Impacts
- Tracheal and airway disorders
- Porphyrin Metabolism and Disorders
- Nursing Diagnosis and Documentation
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Sepsis Diagnosis and Treatment
- Probiotics and Fermented Foods
- Bacterial Infections and Vaccines
- Neonatal and Maternal Infections
- Electronic Health Records Systems
- Environmental Justice and Health Disparities
- Heavy Metal Exposure and Toxicity
- Air Quality and Health Impacts
- Pneumocystis jirovecii pneumonia detection and treatment
- Metabolism and Genetic Disorders
Centers for Disease Control and Prevention
2023-2025
National Center for Emerging and Zoonotic Infectious Diseases
2023-2025
Alaska Native Tribal Health Consortium
2012
Southcentral Foundation
2009-2011
We describe the epidemiology of invasive group B streptococcal (GBS) disease among non-pregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases GBS were reported for an age-adjusted annual incidence 9.1 (95% CI, 8.5-9.7) per 100,000 adults. Incidence increased 1.9-fold 1.6-2.2) between 2004-2013 and 2014-2023. Adults aged ≥65 years had a 4.4-fold higher risk compared to younger adults, 47% with diabetes. Healthcare providers should be aware populations at risk,...
Abstract We used statewide surveillance data to describe the epidemiology of invasive Haemophilus influenzae type a (Hia) disease in Alaska during 2018–2022. Of 52 cases identified, 39 (75%) occurred among Native children aged <5 years who lived rural areas southwest or northern Alaska. Average annual incidence was 17.8 per 100,000 compared 0.3 persons ≥5 years. Among 43 years, 16 (37%) presented with meningitis and 6 (14%) died. Characterizing Hia can help direct prevention...
Abstract Background Adults aged ≥65 years, adults with certain underlying medical conditions, and persons experiencing homelessness are at increased risk for invasive pneumococcal disease (IPD). Two new conjugate vaccines, 15-valent vaccine (PCV15) 20-valent (PCV20), were recently approved use in US adults. We describe the epidemiology of IPD among Alaska estimate proportion cases potentially preventable by vaccines. Methods used statewide, laboratory-based surveillance data to calculate...
Streptococcus pneumoniae can co-infect persons who have viral respiratory tract infections. However, research on S. infections that are temporally associated with SARS-CoV-2 is limited. We described the epidemiology and clinical course of patients had invasive pneumococcal disease (IPD) in Alaska, USA, during January 1, 2020-December 23, 2021. Of 271 laboratory-confirmed IPD, 55 (20%) a positive test result. observed no major differences age, race, sex, or underlying medical conditions among...
This study describes the lifetime prevalence of self-reported asthma among American Indian and Alaska Native (AI/AN) people who participated in Education Research Towards Health (EARTH) Alaska. We conducted a cross-sectional analysis by sex its associations with sociodemographic, health, environmental factors. Among 3,828 AI/AN adults, we found higher age-sex adjusted (15.4%) than is general U.S. adult (11.0%) population based on 2006 National Interview Survey. After multivariable analysis,...
Objective: To examine self-reported safety behaviours among 3828 Alaskan Native and American Indian people enrolled in the Alaska Education Research Towards Health (EARTH) Study, 2004–2006. Design: A cross-sectional analysis of baseline data from a cohort study. non-random sample participants (2322 women 1506 men) aged ⩾18 years three regions completed questions on as part comprehensive health lifestyle computer-assisted self-administered questionnaire. Results: Most reported never driving...